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Abstract
Background:  Inappropriate use of antibiotics by individuals worried about biological agent
exposures during bioterrorism events is an important public health concern. However, little is
documented about the extent to which individuals with self-identified risk of anthrax exposure
approached physicians for antimicrobial prophylaxis during the 2001 bioterrorism attacks in the
United States.
Methods: We conducted a telephone survey of randomly selected members of the Pennsylvania
Chapter of the American College of Emergency Physicians to assess patients' request for and
emergency physicians' prescription of antimicrobial agents during the 2001 anthrax attacks.
Results:  Ninety-seven physicians completed the survey. Sixty-four (66%) respondents had
received requests from patients for anthrax prophylaxis; 16 (25%) of these physicians prescribed
antibiotics to a total of 23 patients. Ten physicians prescribed ciprofloxacin while 8 physicians
prescribed doxycycline.
Conclusion: During the 2001 bioterrorist attacks, the majority of the emergency physicians we
surveyed encountered patients who requested anthrax prophylaxis. Public fears may lead to a high
demand for antibiotic prophylaxis during bioterrorism events. Elucidation of the relationship
between public health response to outbreaks and outcomes would yield insights to ease burden on
frontline clinicians and guide strategies to control inappropriate antibiotic allocation during
bioterrorist events.
Background
The September 11, 2001 terrorism events and the ensuing
anthrax attacks in the United States were associated with
widespread psychological trauma [1]. In response to the
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outbreak, public health officials disseminated recommen-
dations for Bacillus anthracis postexposure prophylaxis
and clinical management of patients with anthrax disease
[2,3]. For asymptomatic persons, antimicrobial prophy-
laxis was indicated only for confirmed or suspected aero-
sol anthrax exposure documented by public health or law
enforcement [4-6].
Public health officials assured the public that emergency
drug supplies would be delivered to clinical settings as
needed from the national antimicrobial stockpile [7].
Despite such assurances and caution against personal
stockpiling and self-medication, media reports of
increased demand for ciprofloxacin indicated a potential
public health problem [8]. However, it was not clear to
what extent individuals with self-identified risk of anthrax
exposure approached physicians for antimicrobial proph-
ylaxis. Additionally, the response of frontline clinicians to
these requests had not been described. To address these
questions, we used data from a large public health survey
of Pennsylvania emergency physicians following the 2001
terrorist attacks [9].
Methods
A total of 250 potential study subjects were randomly
selected from the 2001 membership database (n = 1,060)
of the Pennsylvania Chapter of the American College of
Emergency Physicians (ACEP). Information in the data-
base, such as contact telephone numbers and location of
practice, is provided during enrollment or during mem-
bership renewals, and no active verification is done.
Because the accuracy of the database was unknown, we
used an 80% estimate based on a previous study of emer-
gency physicians [10]. During November 2001-January
2002, we conducted a telephone survey with items
designed to assess requests for and prescriptions of antibi-
otic prophylaxis for anthrax. For the types of antibiotics
prescribed, the survey choices were ciprofloxacin, doxycy-
cline, amoxicillin, penicillin VK, other, or none. Emer-
gency departments with post-graduate training programs
were categorized as "academic" while all others were cate-
gorized as "non-academic." Details concerning survey
instrument design and data collection are described else-
where [9]. Population and administrative data main-
tained by the Pennsylvania Department of Health's
Bureau of Health Statistics were used to stratify respond-
ents by geographic location. Counties with a population
density of ≥ 450 persons per square mile were defined as
"urban" while all others were categorized as "rural." "East-
ern" Pennsylvania was defined as the Southeast and
Northeast Districts of the Pennsylvania Department of
Health. All other locations were considered "western."
We used one-way frequency analyses to describe distribu-
tions of responses for all categorical items. Associations
were quantified using odds ratios (ORs) with associated
95% confidence intervals (CIs). Statistical analyses were
performed using SAS software (SAS Institute Inc., Cary,
NC).
Results
Forty-three of the 250 physicians in the sample were
excluded from the study because of insufficient contact
information or because the physician was no longer prac-
ticing medicine in the state. Of the remaining 207 physi-
cians (24% of the estimated population of 848 subjects
with accurate information), 97 were interviewed (47%
response rate).
Sixty-four (66%) of the 97 respondents had received
patient requests for antimicrobial prophylaxis against
anthrax; of the physicians who received requests, 16
(25%) prescribed antibiotics. Physician setting (urban vs.
rural; eastern vs. western) was not associated with either
patient request for, or physician prescription of, antimi-
crobial prophylaxis (Table 1). Of the 52 respondents in
urban areas, 38 (73%) had received requests for antibiot-
ics while 26 (59%) respondents in rural counties had
received such requests (odds ratio [OR], 1.9; 95% confi-
dence interval [CI], 0.8 – 4.4). Similarly, the type of insti-
tution (academic versus non-academic) was not
associated with requests for or prescriptions of antibiotics.
Fifteen physicians prescribed antibiotic prophylaxis to 23
patients; nine physicians prescribed to one patient, four
prescribed to two patients, and two physicians prescribed
to three patients. One physician did not answer the ques-
tion regarding number of patients prescribed prophylactic
antibiotics. Ten physicians (63%) prescribed cipro-
floxacin while 8 physicians (50%) prescribed doxycycline
(Figure 1). Fourteen (88%) of the respondents that pre-
scribed antibiotics to patients also referred the patients for
diagnostic tests for anthrax exposure.
Discussion
Following the September 11 terrorist attacks and the ensu-
ing anthrax outbreak, the majority of the emergency phy-
sicians we surveyed in Pennsylvania had received patient
requests for anthrax prophylaxis; a quarter of these physi-
cians prescribed antibiotics for these patients. Physicians
that reported patients' requests for antimicrobial prophy-
laxis were distributed across the state, suggesting that
patients' search for protection against anthrax was wide-
spread. Our results are consistent with data on specimens
submitted to Pennsylvania public health laboratory offi-
cials for B. anthracis analysis. During October-December
2001, the Pennsylvania Bureau of Laboratories received
approximately 1400 specimens including white powder,
environmental swabs, and letters from counties in eastern
and western Pennsylvania districts. Of these, 27 (or aboutBMC Public Health 2005, 5:2 http://www.biomedcentral.com/1471-2458/5/2
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18 requests per 100,000 population) came from Cambria
County in the western district (PA DOH: unpublished
data). There were 11,063 anthrax-related telephone
inquiries received from October 8 to November 11, 2001
by the Centers for Disease Control and Prevention's
(CDC) emergency operations centers; queries originated
from all states and one US territory. Most of these calls
were from members of the public concerning anthrax vac-
cines (≈58%), suggesting that search for protective meas-
ures against anthrax was widespread across the United
States [11].
Other studies have documented an increased use of anti-
microbial agents that was temporally related to the
anthrax outbreak; this use could not be ascribed to that
recommended by the CDC. For example, a recent national
study reported that approximately 160,000 more cipro-
floxacin and 96,000 more doxycycline prescriptions were
written in 2001 compared to 2000 [12]. When other
investigators compared ciprofloxacin utilization in 2001
with 2000, they found that it declined for all months
except October 2001 when ciprofloxacin utilization
increased 9.8%. They also found that the increase was not
limited to areas where anthrax cases had occurred, sug-
gesting that many Americans sought antibiotic prophy-
laxis [13].
Of the physicians reporting that they had prescribed anti-
biotics for anthrax prophylaxis, the majority used cipro-
floxacin. This finding is consistent with other studies
[12,13] and is likely because the initial CDC guidelines
recommended ciprofloxacin prophylaxis for B. anthracis
exposure until susceptibility results were known [4,5].
When tests showed that B. anthracis isolates recovered
from patients involved in the anthrax attacks were suscep-
tible to other antibiotics, public health officials indicated
that doxycycline might be preferable over ciprofloxacin
[2]. While both drugs are approved for postexposure
prophylaxis [14], the rationale for favoring doxycycline
was to prevent ciprofloxacin resistance in more common
bacteria.
Unfortunately use of antibiotics has inherent risks and
costs and optimizing benefits is especially difficult in the
midst of bioterrorist events. Consequences of antibiotic
treatment of unexposed individuals include adverse drug
reactions, increased risk of antimicrobial resistance,
depletion of antibiotics, and monetary costs [15]. Further-
Table 1: Physicians' response to patients' requests for anthrax prophylaxis. *
Characteristic




Variable Urban Rural OR (95% CI) Eastern Western OR (95% CI) Academic Non academic OR (95% CI)
Received requests for antibiotics 38 (73) 26 (59) 1.9 (0.8–4.4) 33 (70) 31 (63) 1.4 (0.6–3.2) 21 (68) 41 (66) 1.1 (0.4–2.7)
Prescribed antibiotics for anthrax 10 (20) 6 (14) 1.5 (0.5–4.7) 6 (13) 10 (21) 0.6 (0.2–1.8) 7 (23) 9 (15) 1.8 (0.6–5.4)
Requested testing for anthrax 18 (35) 11 (24) 1.6 (0.7–4.0) 15 (32) 14 (28) 1.2 (0.5–2.9) 8 (26) 21 (33) 0.7 (0.3–1.8)
Abbreviations: OR: Odds ratio; CI: Confidence interval.
* The ninety-seven survey respondents were used in the analysis.
†Fifty-two physicians responded from practices located in one of the eleven "urban" counties that had a population density of ≥450 persons per sq 
mile in 2001.
‡Forty-seven respondents were from eastern Pennsylvania, defined as the Northeast and Southeast Districts.
§Thirty-one physicians responded from practices that were considered "academic" based on presence of training for residents or fellows.
Types of antibiotics prescribed by emergency physicians Figure 1
Types of antibiotics prescribed by emergency physi-
cians. A total of 16 physicians prescribed various antibiotics 
shown above. Fifteen physicians prescribed these types of 
drugs to 23 patients. One physician did not respond to the 
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more, use of emergency departments for sporadic distri-
bution of prophylactic antibiotics to persons presenting
with self-identified risk appears inefficient. It is unclear
whether these persons can be adequately managed in
emergency departments without the support of public
health and law enforcement officials.
Public health response likely influences demand for and
outcomes associated with antibiotics requests during bio-
terrorism attacks. When we asked physicians to suggest on
what health departments could do to reduce the influx of
patients to the emergency departments, they cited official
communications to make the public "less worried." In Illi-
nois, a surge in environmental samples received by public
health officials for anthrax tests was associated with both
media reports of anthrax cases in other states and a spe-
cific announcement on October 29, 2001 by the US attor-
ney general and the FBI director. The announcement
asked US citizens and law enforcement agencies to be on
the "highest alert" based on "credible information" [16].
Lessons learned from the 2001 anthrax attacks in New Jer-
sey suggest that communities in which the public health
sector and clinicians have a strong working relationship
are better prepared to meet mass prophylaxis needs [17].
Similarly, lessons learned in New York City during the
same outbreak demonstrated the benefits of advance
logistical planning for mass postexposure prophylaxis
including an antibiotics distribution site and clear eligibil-
ity criteria [18].
We acknowledge some limitations to our results. First, as
in any survey, these data are subject to non-response bias.
But the 47% response rate is comparable with other tele-
phone surveys conducted among physicians in general
[19]. In addition, responders and non-responders had
similar baseline characteristics, suggesting that these
groups were comparable [9]. Second, the study is limited
to types of antibiotics prescribed and cannot be used to
estimate dosage, number of pills allotted to these patients,
costs, or compliance to treatment for perceived or real
anthrax exposure. Third, the indications for prophylaxis
were not studied. While it is not certain, it is likely that at
least the vast majority of the antibiotic perscriptions
found in this study were outside indications described in
public health guidelines. It is plausible that some patients
sought prescriptions for storage; it is also likely that they
at least initiated the antibiotic course.
Conclusions
Taken together with other recent studies of antibiotic uti-
lization [12,13], these data suggest a need for public
health response to increased demand for prophylaxis
against perceived bioterrorism exposures. Experiences in
areas where mass prophylaxis was delivered and sugges-
tions made by the respondents in this study suggest that
improved public health communications might reduce
the influx of patients to emergency departments. In addi-
tion, as demonstrated by New York City's exemplary
response to the West Nile virus outbreak in 1999 and the
2001 anthrax attacks, prior logistical plans and strong
working relationships among public health officials and
clinicians are essential [18,20]. Elucidation of the rela-
tionship between public health response to outbreaks and
outcomes may offer lessons to reduce inappropriate
demand for and prescriptions of antibiotics during bioter-
rorist events.
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